Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Marwa H. Elkarmalawy"'
Autor:
Sultan Aati, Hanan O. Farouk, Marwa H. Elkarmalawy, Hanan Y. Aati, Nahla Sameh Tolba, Hossam M. Hassan, Mostafa E. Rateb, Doaa S. Hamad
Publikováno v:
Pharmaceutics, Vol 16, Iss 11, p 1432 (2024)
Background: Itraconazole (ITZ) is an antiangiogenic agent recognized as a potent suppressor of endothelial cell growth that suppresses angiogenesis. Nevertheless, its exploitation is significantly restricted by its low bioavailability and systematic
Externí odkaz:
https://doaj.org/article/ec6f5b0447fd4d0f80bb30233e544a4d
Publikováno v:
Drug Delivery, Vol 24, Iss 1, Pp 781-791 (2017)
Loratadine (LTD) is an antihistaminic drug that suffers limited solubility, poor oral bioavailability (owing to extensive first-pass metabolism), and highly variable oral absorption. This study was undertaken to develop and statistically optimize tra
Externí odkaz:
https://doaj.org/article/b364e7c04ee043a8a82597974db06293
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 781-791 (2017)
article-version (VoR) Version of Record
Drug Delivery, Vol 24, Iss 1, Pp 781-791 (2017)
Loratadine (LTD) is an antihistaminic drug that suffers limited solubility, poor oral bioavailability (owing to extensive first-pass metabolism), and highly variable oral absorption. This study was undertaken to develop and statistically optimize tra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d01c91e72f86af52e201172eb16392c4
https://pubmed.ncbi.nlm.nih.gov/28480758
https://pubmed.ncbi.nlm.nih.gov/28480758